Literature DB >> 32629835

Stage Specific Expression Pattern of Alpha-Hemoglobin-Stabilizing-Protein (AHSP) Portrayed in Erythroblast Chronology.

Julia Walczak1, Maria D Camargo Johnson1, Kuzhali Muthumalaiappan1,2.   

Abstract

During erythropoiesis, the molecular chaperone alpha-hemoglobin-stabilizing protein (AHSP) sequesters free alpha-hemoglobin (αHb) and prevents precipitation of excess αHb. While AHSP is linked to hereditary anemia, the pattern of expression during specific erythroblast stages is poorly understood. We investigated gene and protein expressions of AHSP throughout progressive maturation stages of erythroblasts in biphasic cultures of blood and bone marrow samples from healthy donors. Differentiating erythroblasts were periodically subjected to flow cytometry, Amnis imaging and RT-qPCR analyses. We made parallel in vivo validations from naive murine bone marrow cells. Percentages of AHSP+ erythroblasts, protein expressions and AHSP gene expressions are negligible on culture day 6 (CFU-Es) and progressively increases from culture days 8-12 (peaks on day 12) and declines on day 14. Notably, sub-cellular location of AHSP is both in the cytoplasm and nucleus in the early erythroblasts while in the late stages of maturation AHSP is found predominantly in the nucleus, being expelled with it during enucleation. As both human bone marrow and peripheral blood mononuclear cells (PBMC) derived erythroblasts demonstrated similar expression patterns, sampling of erythroblasts from day 11 cultures could portray erythroblast chronology and provide optimum representative stage specific expression patterns. PBMCs may be suitable for comparison studies of AHSP expression in pathologic erythropoiesi.

Entities:  

Keywords:  AHSP; AHSP-flow cytometry; AHSP-gene; Amnis; alpha-hemoglobin-stabilizing-protein; biphasic erythroid culture; enucleation; erythropoiesis; human bone marrow

Year:  2020        PMID: 32629835     DOI: 10.3390/mps3030046

Source DB:  PubMed          Journal:  Methods Protoc        ISSN: 2409-9279


  1 in total

1.  Transient Improvement in Erythropoiesis Is Achieved Via the Chaperone AHSP With Early Administration of Propranolol in Burn Patients.

Authors:  Julia Walczak; Corinne Bunn; Pravesh Saini; Yuk Ming Liu; Anthony J Baldea; Kuzhali Muthumalaiappan
Journal:  J Burn Care Res       Date:  2021-03-04       Impact factor: 1.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.